Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.
|
|
- Osborn Thornton
- 5 years ago
- Views:
Transcription
1 Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical decision making by describing a range of generally acceptable intervention and outcomes. The guidelines attempt to define practices that meet the needs of most patients under most circumstances. However, the ultimate judgment must be made based on circumstances that are relevant to that patient and treatment may be modified according to the individual patients needs.
2
3 PACU Lumbar Fusion Clinical Pathway PAIN MANAGEMENT / COMFORT PAIN GUIDE Preoperative Medications: 1) Acetaminophen Dose: 1000 mg PO Contraindications: severe liver dysfunction, allergy, use within previous 6 hours 2) Pregabalin OR Gabapentin OR Home Dose if taking Mscontin or Oxycontin Doses: Please consider contributions from other sedating agents or medical comorbidities and modify dose accordingly. i. Pregabalin: 150 mg if < 70 yr old and > 70 kg 75 mg if > 70 old or < 70 kg ii. Gabapentin: 600 mg if < 70 yr old and > 70 kg 300 mg if > 70 yr old or < 70 kg Contraindications: renal dysfunction (GFR < 30), allergy Chronic users should receive their scheduled dose in preop holding if they did not take it prior to coming to the hospital. 3) Oxycontin Dose: 10 mg if not taking long-acting narcotic chronically Patients taking MScontin, oxycontin, methadone should receive their regularly scheduled dose instead. Intraoperative Analgesia Management suggestions: 1) Opioids a. Fentanyl: minimize use b. Hydromorphone/Morphine/Methadone: Use intraoperatively as needed. 2) Ketamine: this is useful to spare opioids and to reduce risk of hyperalgesia. It is useful in highly opioid tolerant patients and in neuromonitoring cases. Bolus dosing: mg/kg after induction Drip: mg/kg/hr Side effect profile is minimal using these dosing strategies 3) Dexmedetomidine: This is very effective in highly opioid tolerant patients. Can cause significant sedation in higher doses. Can cause bradycardia and hypotension, dry mucous membranes. Dose: mcg/kg/hr (IBW) Bolus (use great caution) 5-10 mcg q 5 minutes up to 1 mcg/kg IBW 4) Anti-Infectives: Antibiotics are per ID recommendations. These recommendations are posted in the OR or available on the portal. 4) Celecoxib Dose: 400 mg x 1 Contraindications: Significant renal dysfunction, platelet dysfunction Severe CAD Allergy (remember this drug may be problematic in patients with sulfa allergy)
4 Lumbar Fusion Pain Pathway Lumbar Fusion Pain Pathway Excludes Dr. Glazer patients Generalized Pain Pathway Descriptions: A B C Patients that are Opiate Naive: < 60 mg Morphine Equivalent/day Patients that are Opiate Tolerant: > 60 mg Morphine Equivalent/day Patients Intolerant of oral medications or strictly NPO CPS Consult Patients on Methadone, Suboxone, Subutex, Buprenorphine, and Naltrexone IM or for any patient taking > 60 mg morphine equivalents/day for > 2 weeks Epidural? Consult APS (3PAIN) Tolerates PO? Is this a CPS patient? Contact CPS 3OUCH Patient taking < 60 mg morphine/day Pathway A Opioid Naive Is there adequate analgesia? Patient taking > 60 mg morphine/day Pathway B Opioid tolerant Follow CPS plan Prepare discharge plan including: 1) Weaning from opioids 2) PRN-(or) as needed Suboxone, subutex, Naltrexone? CPS/POP Consult required Pathway C IV pathway (least preferred) Patient should be changed to PO ASAP
5 Pathway A: Opiate naïve or uses < 60 mg morphine equivalent/day (see table) B Drug Initial dose Frequency Adjustment options Acetaminophen mg 500 mg Q 6-8 hours Oxycodone 5-10 mg PO Q 4 hours mg Q 4 hours Hydromorphone 2-4 mg PO Q 4 hours 4-6 mg, can give Q 3hours Morphine PO (MSIR) Anticonvulsants Muscle relaxants 15mg PO Q 4 hours ne, contact APS Start with low dose Start with low dose See list below See list below Oxycontin 2 10 mg PO Contact APS MSContin 2 15 mg PO, Contact APS Ketamine drip mg/kg/hr Infusion Contact APS (with APS consult only) Celecoxib mg PO Once/day 200 mg BID 3 x 24 hr Preferred Restrict use 1. Acetaminophen: decrease dose or avoid in patients with liver dysfunction. 2. Consider omitting in opioid naïve patients who are not taking any opioids at baseline. 3. Single preoperative celecoxib dose OK. If celecoxib or ketorolac are needed postop, attending surgeon approval is required. PO Pain Medication Pathways: Patients should remain on all preoperative medications during the hospitalization unless contraindicated for the surgery. Use fewest number of medications required at lowest doses necessary. Limit long-acting opioids to 5 days following discharge unless patients are stabilized on them prior to surgery. Use caution with combining narcotics and sedatives in patients with: o Obstructive sleep apnea o Cognitive dysfunction o Over 70 years old
6 IV breakthrough Pain Medications: Drug Dose Frequency Adjustments Hydromorphone mg Q 4 hours 0.25 mg patients > 70 years old Morphine 1-2 mg Q 4 hours mg Meperidine mg PO/IV/IM Q 6 hours APS/CPS only Anticonvulsant Medications for Pain Management (all PO only): Drug Gabapentin Pregabalin Dose mg (naïve) mg Frequency Adjustments 300 mg-900 mg Q 8 hr mg Q 12 hr 1) Decrease the dose in renal insufficiency 2) Decrease the dose in patients > 70 years old. Topiramate mg (APS/CPS only unless stabilized on drug) Muscle Relaxants for Pain Management: mg/day 3) Use caution (avoid) in patients with cognitive dysfunction. Drug Diazepam Lorazepam Dose 5 mg PO mg PO Frequency BID-QID prn BID-TID prn Adjustments 10 mg BID-QID 2 mg BID-TID 1. Increased risk of serotonin syndrome when used in patients on SSRIs. 2. Initiate with recommendation by APS or CPS only. Continue drug if patient has Flexeril 1 (cyclo- 5 mg PO 10 mg benzaprine) been stabilized on one of these drugs preoperatively. Skelaxin (metaxalone) Robaxin (methocarbamol) Baclofen PO Baclofen pump 800 mg PO 500 mg PO 5 mg PO Consult CPS for interrogation preop and postop -2 adrenergic agonists: Q 4 hours 800 mg Q 6 hours 1000 mg Q 6 hours, 1500 mg x 48 hours mg With all of these drugs use great caution in patients > 70 years old. They may increase the risk of delirium especially in combination with other medications. If patient is stabilized on regimen, please consider modifying dose rather than adding another drug in the same class. Drug Dose Frequency Adjustments These drugs should be initiated by APS Clonidine 0.1 mg PO Q 12 hr 0.2 mg Q 12 hrs or CPS only. over several days Clonidine transdermal 0.1 mg patch Q 7 days none Tizanidine 2-4 mg PO 4 mg Q 8 hrs after several days Morphine Equivalents (in mg/day): If patients are taking these preoperatively, do NOT discontinue abruptly. Avoid in patients > 70 years old unless stabilized on regimen. Drug IV PO Methadone and buprenorphine equivalents are controversial. Morphine Sulfate 20 mg 60 mg Do not make adjustments without consulting CPS or APS. Oxycodone n/a 40 mg Consult CPS for patients on Methadone, Suboxone, Subutex, buprenorphine, Naltrexone IM or for any patient taking Hydromorphone 4 mg 20 mg greater than 60 mg morphine equivalents per day for greater Oxycontin n/a 40mg than 2 weeks. MSContin n/a 60 mg Fentanyl patch 25 mcg/hr n/a Oxymorphone n/a mg
7 Pathway B: Opiate tolerant patients (> 60 mg morphine equivalents/day) C. a) These patients should have a preoperative POP consult with CPS. b) If patients do not have a CPS or POP consult, please use the suggested doses listed below. Consider APS consult. c) Please use IV breakthrough narcotics as listed for opiate-naïve patients Drug Initial dose Frequency Adjustment options Oxycodone mg PO Q 4 hours 20 mg Q 4 hours Hydromorphone 4-6 mg PO Q 4 hours 4-8 mg, may give Q 3hours Morphine PO (MSIR) 15-30mg PO Q 4 hours 30 mg Q 4 hours Acetaminophen 1000 mg PO 500 mg Q 6-8 hours 1 Anticonvulsants 4 Muscle relaxant Oxycontin MSContin Clonidine (APS consult unless patient taking preoperatively) Ketamine drip (APS consult required) Start with low dose. (see note 4 below) Start with low dose. 10 mg (or preoperative dose) 15 mg (or preoperative dose) 0.1 mg patch +/- tablet Q 8-12 hours Q 7 days See list below See list below mg/kg/hr Infusion Contact APS 2 Use APS/CPS recommended dose Use APS/CPS recommended dose Contact APS for any dosing adjustments Celecoxib mg PO Once/day After initial dose: 200 mg BID 3 Preferred Restrict use 1. Acetaminophen: decrease dose or avoid in patients with liver dysfunction. 2. APS will manage ketamine infusions in conjunction with CPS. 3. Single preoperative dose Celecoxib permitted. If celecoxib or ketorolac are needed postop, attending surgeon approval is required. 4. Patients who have been stabilized on anticonvulsants should continue on preoperative dose. Consider increasing dose for inadequate analgesia if patients are having pain and are not overly sedated. PO Pain Medication Pathways: Patients should remain on all preoperative medications during the hospitalization unless contraindicated for the surgery. Use fewest number of medications required at lowest doses necessary. Limit long-acting opioids to 5 days following discharge unless patients are stabilized on them prior to surgery. Use caution with combining narcotics and sedatives in patients with: o Obstructive sleep apnea, o Cognitive dysfunction o Over 70 years old.
8 IV breakthrough Pain Medications: Drug Dose Frequency Adjustments Hydromorphone mg Q 4 hours 0.25 mg patients > 70 years old Morphine 1-2 mg Q 4 hours mg Meperidine mg PO/IV/IM Q 6 hours APS/CPS only Anticonvulsant Medications for Pain Management (all PO only): Drug Gabapentin Pregabalin Dose mg (naïve) mg Frequency Adjustments 300 mg-900 mg Q 8 hr mg Q 12 hr 1) Decrease the dose in renal insufficiency 2) Decrease the dose in patients > 70 years old. Topiramate mg (APS/CPS only unless stabilized on drug) Muscle Relaxants for Pain Management: mg/day 3) Use caution (avoid) in patients with cognitive dysfunction. Drug Diazepam Lorazepam Dose 5 mg PO mg PO Frequency BID-QID prn BID-TID prn Adjustments 10 mg BID-QID 2 mg BID-TID 1. Increased risk of serotonin syndrome when used in patients on SSRIs. 2. Initiate with recommendation by APS or CPS only. Continue drug if patient has Flexeril 1 (cyclo- 5 mg PO 10 mg benzaprine) been stabilized on one of these drugs preoperatively. Skelaxin (metaxalone) Robaxin (methocarbamol) Baclofen PO Baclofen pump 800 mg PO 500 mg PO 5 mg PO Consult CPS for interrogation preop and postop -2 adrenergic agonists: Q 4 hours 800 mg Q 6 hours 1000 mg Q 6 hours, 1500 mg x 48 hours mg With all of these drugs use great caution in patients > 70 years old. They may increase the risk of delirium especially in combination with other medications. If patient is stabilized on regimen, please consider modifying dose rather than adding another drug in the same class. Drug Dose Frequency Adjustments These drugs should be initiated by APS Clonidine 0.1 mg PO Q 12 hr 0.2 mg Q 12 hrs or CPS only. over several days Clonidine transdermal 0.1 mg patch Q 7 days none Tizanidine 2-4 mg PO 4 mg Q 8 hrs after several days Morphine Equivalents (in mg/day): If patients are taking these preoperatively, do NOT discontinue abruptly. Avoid in patients > 70 years old unless stabilized on regimen. Drug IV PO Methadone and buprenorphine equivalents are controversial. Morphine Sulfate 20 mg 60 mg Do not make adjustments without consulting CPS or APS. Oxycodone n/a 40 mg Consult CPS for patients on Methadone, Suboxone, Subutex, buprenorphine, Naltrexone IM or for any patient taking Hydromorphone 4 mg 20 mg greater than 60 mg morphine equivalents per day for greater Oxycontin n/a 40mg than 2 weeks. MSContin n/a 60 mg Fentanyl patch 25 mcg/hr n/a Oxymorphone n/a mg
9 Pathway C: IV Pathway Primary use of IV analgesia should be reserved for patients who are: 1) Strictly NPO 2) Intolerant of PO analgesia due to N/V or other gastrointestinal concerns. Avoid mixing IV and PO pathways without consultation from APS or CPS. Drug Dose Frequency Adjustments PCA hydromorphone mg Q 6 min Up to 0.36 mg Q 6 min. Preferred PCA morphine mg Q 6 min Up to 2 mg Q 6 min. Acetaminophen 1000 mg IV Q 6 hours 500 mg Q 6 hours or 1000 mg. Lorazepam mg IV/IM Q 6-8 hours mg IV Q 6-8 hours 1 Diazepam 5 mg IV/IM Q 6-8 hours 10 mg IV Q 6-8 hours 1 Ketorolac mg Q 6hr x 48 hr 1. Respiratory depression risk is high when combined with opioids. This is increased in patients with OSA, > 70 years old, those with cognitive or neurological dysfunction. Diazepam had active metabolites that result in increased sedative effects over time. 2. Must have attending surgeon approval before administering NSAIDS. Restrict use Contact APS for management of pain in post-operative patients with inadequate analgesia despite use of pathway medications. The number on the VAS may not reflect clinical picture. Consider baseline pain score. Contact CPS for management of patients with a POP consult. If you are not sure, call APS. PO Pain Medication Pathways: Patients should remain on all preoperative medications during the hospitalization unless contraindicated for the surgery. Use fewest number of medications required at lowest doses necessary. Limit long-acting opioids to 5 days following discharge unless patients are stabilized on them prior to surgery. Use caution with combining narcotics and sedatives in patients with: o Obstructive sleep apnea o Cognitive dysfunction o Over 70 years old
10 IV breakthrough Pain Medications: Drug Dose Frequency Adjustments Hydromorphone mg Q 4 hours 0.25 mg patients > 70 years old Morphine 1-2 mg Q 4 hours mg Meperidine mg PO/IV/IM Q 6 hours APS/CPS only Anticonvulsant Medications for Pain Management (all PO only): Drug Gabapentin Pregabalin Dose mg (naïve) mg Frequency Adjustments 300 mg-900 mg Q 8 hr mg Q 12 hr 1) Decrease the dose in renal insufficiency 2) Decrease the dose in patients > 70 years old. Topiramate mg (APS/CPS only unless stabilized on drug) Muscle Relaxants for Pain Management: mg/day 3) Use caution (avoid) in patients with cognitive dysfunction. Drug Diazepam Lorazepam Dose 5 mg PO mg PO Frequency BID-QID prn BID-TID prn Adjustments 10 mg BID-QID 2 mg BID-TID 1. Increased risk of serotonin syndrome when used in patients on SSRIs. 2. Initiate with recommendation by APS or CPS only. Continue drug if patient has Flexeril 1 (cyclo- 5 mg PO 10 mg benzaprine) been stabilized on one of these drugs preoperatively. Skelaxin (metaxalone) Robaxin (methocarbamol) Baclofen PO Baclofen pump 800 mg PO 500 mg PO 5 mg PO Consult CPS for interrogation preop and postop -2 adrenergic agonists: Q 4 hours 800 mg Q 6 hours 1000 mg Q 6 hours, 1500 mg x 48 hours mg With all of these drugs use great caution in patients > 70 years old. They may increase the risk of delirium especially in combination with other medications. If patient is stabilized on regimen, please consider modifying dose rather than adding another drug in the same class. Drug Dose Frequency Adjustments These drugs should be initiated by APS Clonidine 0.1 mg PO Q 12 hr 0.2 mg Q 12 hrs or CPS only. over several days Clonidine transdermal 0.1 mg patch Q 7 days none Tizanidine 2-4 mg PO 4 mg Q 8 hrs after several days Morphine Equivalents (in mg/day): If patients are taking these preoperatively, do NOT discontinue abruptly. Avoid in patients > 70 years old unless stabilized on regimen. Drug IV PO Methadone and buprenorphine equivalents are controversial. Morphine Sulfate 20 mg 60 mg Do not make adjustments without consulting CPS or APS. Oxycodone n/a 40 mg Consult CPS for patients on Methadone, Suboxone, Subutex, buprenorphine, Naltrexone IM or for any patient taking Hydromorphone 4 mg 20 mg greater than 60 mg morphine equivalents per day for greater Oxycontin n/a 40mg than 2 weeks. MSContin n/a 60 mg Fentanyl patch 25 mcg/hr n/a Oxymorphone n/a mg
11 Pain Management Lumbar Fusion Clinical Pathway 2015 What: Who: Why: Clinical Pathway Practice Changes Lumbar Fusion Patients Clinical Pathway Education related to Pain Management, Mobility, Patient Education, and Discharge Planning Goals: 1. Improved Pain Management with Early Utilization of Oral Pain Medications 2. Increase Early Mobilization to Prevent or Decrease Post-Operative Risk Factors. (ie. Ileus, Blood Clots, and Infections) 3. Improve Documentation of Patient Progress related to pain and mobility. 4. Enhanced Continuous Patient Education and Discharge Planning 5. Decrease the Length of Stay in the Patients S/P Lumbar Fusion Generalized Pain Pathway Descriptions: A Patients that are Opiate Naive: < 60 mg Morphine Equivalent/day B Patients that are Opiate Tolerant: > 60 mg Morphine Equivalent/day C Patients Intolerant of oral medications or strictly NPO CPS Consult Patients on Methadone, Suboxone, Subutex, Buprenorphine, and Naltrexone IM or for any patient taking > 60 mg morphine equivalents/day for > 2 weeks Important Practice Changes for the Lumbar Fusion Pathway Documentation Clinical Pathway in Patient s Chart Actual designation of a Pain Pathway A, B, C, or CPS Consult Use of pre-op oral pain medications: Gabapentin, Tylenol, Oxycontin/MS Contin use of PCA s post-op: Utilizing oral pain medications immediately post op, along with IV pain medications for breakthrough pain instead of PCA: Overview of doses OK to use full dose Explain adjustment options Strict Q4H pain check-ins Important to stay ahead of the pain Set appropriate expectations with the patient (language?) Wake patients at night Bracing If a brace is indicated, use of prefabricated braces are issued to patients by POD 0/POD 1. (Exception of Dr. Glazer s patients) Activity Early Mobilization by Nursing. PT Eval and Treatment: POD#2 and POD#4. Other Use of standing PO Bowel Medications and addition of SC Methylnaltrexone POD 1 Use of PO Flomax POD #1 in men ages 55 years of age or older Starting SC Heparin POD #1, unless patient is ambulating STANDARDIZED PATHWAY VALUE Better Pain Management Increased Mobility, Decreased Risk Factors
12 Lumbar Fusion Pain Pathway Lumbar Fusion Pain Pathway Excludes Dr. Glazer patients Generalized Pain Pathway Descriptions: A B C Patients that are Opiate Naive: < 60 mg Morphine Equivalent/day Patients that are Opiate Tolerant: > 60 mg Morphine Equivalent/day Patients Intolerant of oral medications or strictly NPO CPS Consult Patients on Methadone, Suboxone, Subutex, Buprenorphine, and Naltrexone IM or for any patient taking > 60 mg morphine equivalents/day for > 2 weeks Epidural? Consult APS (3PAIN) Tolerates PO? Is this a CPS patient? Contact CPS 3OUCH Patient taking < 60 mg morphine/day Pathway A Opioid Naive Is there adequate analgesia? Patient taking > 60 mg morphine/day Pathway B Opioid tolerant Follow CPS plan Prepare discharge plan including: 1) Weaning from opioids 2) PRN-(or) as needed Suboxone, subutex, Naltrexone? CPS/POP Consult required Pathway C IV pathway (least preferred) Patient should be changed to PO ASAP
PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose
NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,
More informationAppendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline
Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline 1. Pharmacist to order Narcotic Withdrawal Scores QH X 4 hours, then per table below: Narcotic Withdrawal Score
More informationOverview of Essentials of Pain Management. Updated 11/2016
0 Overview of Essentials of Pain Management Updated 11/2016 1 Overview of Essentials of Pain Management 1. Assess pain intensity on a 0 10 scale in which 0 = no pain at all and 10 = the worst pain imaginable.
More informationSession II. Learning Objectives for Session II. Key Principles of Safe Prescribing. Benefits and Limitations of ER/LA Opioids
Learning Objectives for Session II Session II Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between Upon completion of this module, the participants will be
More informationUpdate on Pain: Collaborative Care for the Complex Patient
Update on Pain: Collaborative Care for the Complex Patient Nirmala R. Abraham, MD Medical Director Sycamore Pain Management Center Kettering Health Network Objectives Standardized approach to patient care
More informationPEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:.
- Phase:. PHYSICIAN S Diagnosis Weight Allergies DETAILS Patient Care Patient Activity Bedrest Maintain Surgical Drain Maintain JP Drain, Measure Output q12h, and PRN Convert IV to INT when tolerating
More informationNo Pain, No Gain Pharmacy Patient Pain Counseling Competition
No Pain, No Gain Pharmacy Patient Pain Counseling Competition Offered by the Maine Pharmacy Association as part of the 2010 MPA Fall Conference Sponsored by an educational grant by NASPA and Purdue Pharma,
More informationScreening - inclusion criteria
PAIN OUT Community research EU ROP EAN COMMISSION A Date of data collection: B Time of data collection: C Ward where data is collected: 2 0 1 Y M M D D H H M M D Research assistant Code: Room number: Screening
More informationFighting the Good Fight: How to Convert Opioids Just Right!
Fighting the Good Fight: How to Convert Opioids Just Right! Tanya J. Uritsky, PharmD, BCPS, CPE Clinical Pharmacy Specialist - Pain Medication Stewardship Hospital of the University of Pennsylvania - Philadelphia,
More informationUse of PCA devices in Difficult Populations
Use of PCA devices in Difficult Populations Diane M. Santangelo MS RN ANP-C Stony Brook University Medical Center Acute Pain Service September 10, 2011 1 PCA technology? Why Bother? Costly Nurses complain:
More informationScreening - inclusion criteria
A Date of data collection: B Time of data collection: C Ward where data is collected: 2 0 1 Y M M D D H H M M D Research assistant Code: Patient code (local): Room number: Screening - inclusion criteria
More informationAssessment. Consults & Referrals
University of Virginia Health System Clinical Pathway: Whipple Enhanced Recovery After () LOS: 4-5 days Date of Origin/Revision: June 29, 2016/September 6, 2017/January 31, 2018 : SAS : : : D1 D2 D 3/
More informationTreating Acute Pain in Patients Being Treated for Opioid Use Disorder
Treating Acute Pain in Patients Being Treated for Opioid Use Disorder Michael McNett, MD Medical Director for Chronic Pain Aurora GMS Some Background In 2015, the incidence of opioid use disorder (OUD)
More information10/1/2018. Treating Acute Pain in Patients Being Treated for Opioid Use Disorder Michael McNett, MD Medical Director for Chronic Pain Aurora GMS
Treating Acute Pain in Patients Being Treated for Opioid Use Disorder Michael McNett, MD Medical Director for Chronic Pain Aurora GMS Some Background In 2015, the incidence of opioid use disorder (OUD)
More informationSTARSHIP WITHDRAWAL OF ANALGESIA AND SEDATION
STARSHIP WITHDRAWAL OF ANALGESIA AND SEDATION Patients receiving analgesia and/or sedation for longer than 5-7 days may suffer withdrawal if these drugs are suddenly stopped. To prevent this happening
More informationEquianalgesic Dosing: Making Opioid Interchange Easier. Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine
Equianalgesic Dosing: Making Opioid Interchange Easier Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine 1 Why Change Opioids? Side Effects Insufficient Pain
More informationAPPENDIX E: HEALTHCARE PRACTITIONER- REPORTED REDUCTION OF PAIN MEDICATION
Contents Appendix E: Healthcare Practitioner-Reported Reduction of Pain Medication... E-1 Appendix E: Healthcare Practitioner- Reported Reduction of Pain Medication Note: Word choice and spellings have
More informationPain management. Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD
Pain management Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD Case #1 61 yo man with history of Stage 3 colon cancer, s/p resection and adjuvant chemotherapy with FOLFOX
More informationBaptist Health Lexington. ERAS Protocols
Baptist Health Lexington ERAS Protocols Enhanced Recovery After Surgery BHLex Colorectal ERAS Protocol Preoperative Patient/Family Education: PAT and office, ERAS brochure & educational flyer/checklist
More informationLearning Objectives. Perioperative goals. Acute Pain in the Chronic Pain Patient for Ambulatory Surgery 9/8/16
Acute Pain in the Chronic Pain Patient for Ambulatory Surgery Danielle Ludwin, MD Associate Professor of Anesthesiology Division of Regional and Orthopedic Anesthesia Columbia University Medical Center
More informationAcute Postoperative Pain. David Radvinsky, MD March 24, 2016
Acute Postoperative Pain David Radvinsky, MD March 24, 2016 Objectives 1. Discuss the multimodal approach to pain management and discuss the various classes of drugs based on receptor mechanism. 2. Give
More information(30689) PROT Pain PCA Adult Patient Controlled Analgesia
Diagnosis Allergies Nursing Assess and Document PCA: 1. Assess and document pain rating, sedation level and respiratory rate every 2 hours; assess and document pain rating, sedation level and respiratory
More informationPEDIATRIC SPINE SURGERY POST-OP PLAN - Phase: Pediatric Spine Surgery General Orders
- Phase: Pediatric Spine Surgery General Orders PHYSICIAN S Diagnosis Weight Allergies Patient Care Patient Activity Bedrest Maintain Surgical Drain Maintain JP Drain, Measure Output q12h, and PRN Convert
More informationGabapentin Does Not Improve Analgesia Outcomes For Total Joint Replacement. Manyat Nantha-Aree, MD
Gabapentin Does Not Improve Analgesia Outcomes For Total Joint Replacement Manyat Nantha-Aree, MD Objective n Preliminary results of MOBILE study in total hip and knee arthroplasty Background n Gabapentin=
More information4/3/2018. Management of Acute Pain Crises. Five Mistakes I ve made and why you shouldn t
Management of Acute Pain Crises Maggie O Connor, M.D. Retired Palliative Care Physician Hope is not the conviction that something will turn out well, but the certainty that something makes sense, regardless
More informationAnalgesics: Management of Pain In the Elderly Handout Package
Analgesics: Management of Pain In the Elderly Handout Package Analgesics: Management of Pain in the Elderly Each patient or resident and their pain problem is unique. A complete assessment should be performed
More information15mg oxycodone is equivalent to how much morphine
15mg oxycodone is equivalent to how much morphine The Borg System is 100 % 15mg oxycodone is equivalent to how much morphine nursing home activity director cover letter 15 mg oxycodone equal to how much
More informationDrug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA opioid analgesics) Avinza Butrans
FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics 7/9/2012 Drug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA
More informationPain and the MGH Promise
Pain is an unpleasant sensory & emotional experience associated with actual or potential tissue damage or described in terms of such damage Our promise to patients we will always: Work as a team to evaluate,
More information10 mg hydrocodone equals how much oxycodone
Cari untuk: Cari Cari 10 mg hydrocodone equals how much oxycodone Posts about dilaudid 8 vs oxycodone 30 written by buyprescriptionmedication. Can you help me with the conversion of Oxycodone IR (5mg tab)
More informationReducing the risk of patient harm: A focus on opioids
Reducing the risk of patient harm: A focus on opioids New York State Partnership for Patients (NYSPFP) Initiative Regional Educational Session November 2013 1 Disclosure Matthew Fricker, Matthew Grissinger,
More informationPAIN PODCAST SHOW NOTES:
PAIN PODCAST SHOW NOTES: Dallas Holladay, DO Ultrasound Fellow Cook County Hospital Rush University Medical Center Jonathan D. Alterie, DO PGY-2, Emergency Medicine Midwestern University An overview of
More informationPOST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS
POST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS November 9, 2018 Aimee LaMere, CNP Molly McNaughton, CNP Leslie Weide, MSW, LICSW, ACM Disclosures: Conflict of interest statement: We certify that,
More informationWhat to do when you are called to see a patient with... PAIN. Susan Merel, MD Division of General Internal Medicine July 2018
What to do when you are called to see a patient with... PAIN Susan Merel, MD Division of General Internal Medicine July 2018 Disclosures Susan Merel has no relationships with any entity producing, marketing,
More informationPain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN
Pain Management and Safe use of opioids in hospitals Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN Bronx Care Health System Bronx Lebanon Hospital Concourse/ Fulton division, Nursing
More informationUCSF: 150 years in the making
Securing Hospital Approval for Ketamine use on the Wards: Challenges, Outcomes and Lessons Learned Acknowledgements Mark Schumacher Ph.D.,M.D. Professor and Chief, Division of Pain Medicine Dept. of Anesthesia
More informationFairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45
Fairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45 1. Your diabetic patient is to be started on an insulin drip at 8 units/hour. The insulin is supplied: 100 units in
More informationOpioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory
Opioids: Use, Abuse and Cause of Death Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory jharmon@occl.ocgov.com Opioid: Any psychoactive chemical that resembles morphine
More informationPain Management Dilemmas. Five Pain Dilemmas. Barriers: Meet Loretta. Daniel Johnson, MD, FAAHPM
Pain Management Dilemmas Daniel Johnson, MD, FAAHPM Kaiser Permanente University of Colorado Five Pain Dilemmas 1. Barriers to Pain Management 2. Selecting and Titrating Opioids 3. Managing PCAs 4. Using
More informationBalanced Analgesia With NSAIDS and Coxibs. Raymond S. Sinatra MD, Ph.D
Balanced Analgesia With NSAIDS and Coxibs Raymond S. Sinatra MD, Ph.D Prostaglandins and Pain The primary noxious mediator released from damaged tissue is prostaglandin (PG) PG is responsible for nociceptor
More informationAmber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center
Pharmacologic Management of Pain Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center Objectives Identify types of
More informationOpioid Pearls and Acute Pain Management
Opioid Pearls and Acute Pain Management Jeanie Youngwerth, MD University of Colorado Denver Assistant Professor of Medicine, Hospitalist Associate Director, Colorado Palliative Medicine Fellowship Program
More information1/21/14. Cancer Related Pain: Case-Based Pharmacology. Conflicts of Interest. Learning Objective
Cancer Related Pain: Case-Based Pharmacology Jeannine M. Brant, PhD, APRN, AOCN Oncology Clinical Nurse Specialist Nurse Scientist Billings Clinic Conflicts of Interest Jeannine Brant has served on the
More informationPresentation objectives. Overcoming Acute Pain Management Hurdles in the Tertiary Setting The High Risk Patient
Overcoming Acute Pain Management Hurdles in the Tertiary Setting The High Risk Patient Ewan McNicol PharmD, MS Presentation objectives Outline principles for management of acute pain, with focus on perioperative
More informationAcute Pain Management in the Hospital Setting. Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX
Acute Pain Management in the Hospital Setting Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX 2 What is Pain? An unpleasant sensory and emotional experience associated
More informationPain Management in the Surgical Patient. Peter Vogel, VMD, DACVS
Pain Management in the Surgical Patient Peter Vogel, VMD, DACVS Pain Pathways u Specialized neurons that travel through the spinal cord u Free nerve endings in skin, connective tissue, muscle and bone
More informationBASICS OF OPIOID PRESCRIBING 10:30-11:45AM
PROVIDING QUALITY CARE TO PAIN PATIENTS IN IOWA BASICS OF OPIOID PRESCRIBING 10:30-11:45AM ACPE UAN: 107-000-14-013-L01-P Activity Type: Application-Based 0.125 CEU/1.25hr Learning Objectives for Pharmacists:
More informationPrior Authorization Guideline
Guideline GL-35952 Opioid Quantity Limit Overrides Formulary OptumRx Formulary Note: Approval Date 7/10/2017 Revision Date 7/10/2017 Technician Note: P&T Approval Date: 2/16/2010; P&T Revision Date: 7/12/2011
More informationmorphine 30 mg/ 30 ml (1 mg/ml) Opioid of choice
PATIENT CONTROLLED ANALGESIA (PCA) PLAN Allergies: Medication Selection: morphine 30 mg/ 30 ml (1 mg/ml) Opioid of choice HYDROmorphone (Dilaudid ) 6 mg/ 30 ml (0.2 mg/ml) fentanyl 300 mcg/ 30 ml (10 mcg/ml)
More informationAnesthesia for OutPatient Spine Surgery. Michael A. Kellams, D.O.
Anesthesia for OutPatient Spine Surgery Michael A. Kellams, D.O. DISCLOSURE None! Hot Topics 2017 -Multimodal Analgesia/ERAS -TAP block -Inpatient procedures outpatient (Fusions) Multimodal Analgesia -Using
More information2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio (740) ~
2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio 43130 (740) 687-8000 ~ www.fmchealth.org Introduction The purpose of this module is to reduce the risk of adverse outcomes for adult patients
More informationOpioid Conversion Guidelines
Opioid Conversion Guidelines March 2015 Gippsland Region Palliative Care Consortium Clinical Practice Group Title Keywords Ratified Opioid, Conversion, Drug, Therapy, Palliative, Guideline, Palliative,
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.CPA.259 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important regulatory
More informationAcute pain management in opioid tolerant patients. Muhammad Laklouk
Acute pain management in opioid tolerant patients Muhammad Laklouk General principles An adequate review and assessment Provision of effective analgesia (including attenuation of tolerance and hyperalgesia)
More informationPrescribers of Opioids
Pain Management in Primary Care Part Two Joshua D. Dion MSN, APRN-BC, ACNP Prescribers of Opioids Know how to start, modify, and discontinue opioids. Know how to convert from SA to LA or change from on
More informationNerve Blocks & Long Acting Analgesia for Plastic Surgeons. Karol A Gutowski, MD, FACS
Nerve Blocks & Long Acting Analgesia for Plastic Surgeons Karol A Gutowski, MD, FACS Disclosures None related to this topic Why is Non-Opioid Analgesia Important Opioid epidemic Less opioid use Less PONV
More informationGUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117
More informationPain Module. Top Ten Pain Safety Tips
Pain Module Top Ten Pain Safety Tips # 1 Monitor Your Patient s Level of Consciousness and Respiratory Status Do not depend on alarms to save your patient s life. You must perform your own assessments
More informationHOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain
Due to the high level of prescription drug use and abuse in Lake County, these guidelines have been developed to standardize prescribing habits and limit risk of unintended harm when prescribing opioid
More informationDemystifying Opioid Conversion Calculations
Demystifying Opioid Conversion Calculations Stephanie Cheng, PharmD, MPH, BCGP Clinical Pharmacist Hospice Pharmacy Solutions November 28, 2018 Learning Objectives After this presentation, you should be
More informationOpioid Case Studies. Thomas P. Pittelkow, D.O., M.P.H. Mayo Clinic College of Medicine Rochester, MN. September 29, MFMER slide-1
Opioid Case Studies Thomas P. Pittelkow, D.O., M.P.H. Mayo Clinic College of Medicine Rochester, MN September 29, 2016 2015 MFMER slide-1 Disclosures Relevant Financial Relationship(s) None Off Label and/or
More informationPALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST
PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST TREATMENT IN ONCOLOGY Main treatment : surgery Neoadjuvant treatment : RT, CMT Adjuvant treatment : Tx micrometastatic disease -CMT,Targeted
More informationManaging Pain in Individuals with Serious Illness and Comorbid Substance Use Disorder
Managing Pain in Individuals with Serious Illness and Comorbid Substance Use Disorder Presented by: Kathleen Broglio, DNP, ANP-BC, ACHPN, CPE, FPCN on December 1, 2016 Webcast Questions and Answers (Answers
More informationLong-Acting Opioid Analgesics
Market DC Long-Acting Opioid Analgesics Override(s) Prior Authorization Step Therapy Quantity Limit Approval Duration Initial request: 3 months Maintenance Therapy: Additional prior authorization required
More informationMultimodal perioperative pain management protocols
Multimodal perioperative pain management protocols Nader M. Hebela, MD كليفالند كلينك أبوظبي Dhabi Cleveland Clinic Abu معهد األعصاب Institute Neurological slide count: 30 January 2016 title slide explained
More informationSatisfactory Analgesia Minimal Emesis in Day Surgeries. (SAME-Day study) A Randomized Control Trial Comparing Morphine and Hydromorphone
Satisfactory Analgesia Minimal Emesis in Day Surgeries (SAME-Day study) A Randomized Control Trial Comparing Morphine and Hydromorphone HARSHA SHANTHANNA ASSISTANT PROFESSOR ANESTHESIOLOGY MCMASTER UNIVERSITY
More informationLong-Acting Opioid Analgesics
Market DC Long-Acting Opioid Analgesics Override(s) Prior Authorization Step Therapy Quantity Limit Approval Duration Initial request: 3 months Maintenance Therapy: Additional prior authorization required
More informationPost-caesarean analgesia. Genevieve Goulding Royal Brisbane & Women's Hospital 1
Post-caesarean analgesia Genevieve Goulding Royal Brisbane & Women's Hospital 1 Contemporary challenges & barriers to providing optimal post-caesarean analgesia Genevieve Goulding Royal Brisbane & Women's
More informationPhysician Orders ADULT: ANES Enhanced Recovery After Surgery (ERAS) Plan
Initiate Orders Phase Non Categorized R Powerplan Open Care Sets/Protocols/PowerPlans Initiate Powerplan Phase Phase: Anes (ERAS) Pre-insertion Phase, When to Initiate: Other-See Special Instructions,
More informationPalliative Prescribing - Pain
Palliative Prescribing - Pain LAURA BARNFIELD 21/2/17 Aims To understand the classes of painkillers available in palliative care To gain confidence in counselling regarding opiates To gain confidence prescribing
More informationWHS POSTOPERATIVE POWERPLAN CHANGES
Medications simplified and standardized to improve safety and effectiveness in the management of pain, itching, nausea/vomiting. Management: o The Anesthesiologist will continue to manage pain in the PACU.
More informationOpioid Conversions Mixture of Science and Art
Opioid Conversions Mixture of Science and Art Matthew J. Pingree, MD Assistant Professor Division of Pain Medicine Physical Medicine and Rehabilitation and Anesthesiology Mayo Clinic, Rochester Pingree.Matthew@Mayo.edu
More information15 mg morphine 10 mg hydrocodone
Cari untuk: Cari Cari 15 mg morphine 10 mg hydrocodone 3-2-2013 Convert From CALCULATED MORPHINE EQUIVALENT BY RESOURCE: Average ( mg ) Range ( mg ) Standard Deviation of Sample ( mg ) Hydrocodone. I usually
More informationBuprenorphine pharmacology
Buprenorphine pharmacology Victorian Opioid Management ECHO Department of Addiction Medicine St Vincent s Hospital Melbourne 2018 Page 1 Opioids full, partial, antagonist Full Agonists - bind completely
More informationAssociate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008
Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008 PAIN MECHANISMS Somatic Nociceptive Visceral Inflammatory response sensitizes
More informationCLINICAL POLICY DEPARTMENT: Medical
IMPTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of currently available generally
More informationCHAMP: Bedside Teaching TREATING PAIN. Stacie Levine MD. What is the approach to treating pain in the aging adult patient?
CHAMP: Bedside Teaching TREATING PAIN Stacie Levine MD Teaching Trigger: An older adult patient is identified as having pain. Clinical Question: What is the approach to treating pain in the aging adult
More informationContents. Appendix G: Healthcare Practitioner-Reported Clinical Observations... G-1
Contents Appendix G: Healthcare Practitioner-Reported Clinical Observations... G-1 Appendix G: Healthcare Practitioner- Reported Clinical Observations Note: Word choice and spellings have been retained
More informationPAIN MANAGEMENT PGY-1. Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC
PAIN MANAGEMENT PGY-1 Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC Perception Matters A builder aged 29 came to the accident and emergency
More information1
Disclosures I do not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies for this continuing education activity, or any affiliation with
More informationdisease or in clients who consume alcohol on a regular basis. bilirubin
NON-OPIOID Acetaminophen(Tylenol) Therapeutic class: Analgesic, antipyretic Aspirin (ASA, Acetylsalicylic Acid) Analgesic, NSAID, antipyretic Non-Opioid Analgesics COMMON USES WHAT I NEED TO KNOW AS A
More informationMORPHINE ADMINISTRATION
Introduction Individualised Administration Drug of Choice Route of Administration & Doses Monitoring of Neonates & high risk patients Team Management Responsibility Morphine Protocol Flow Chart Introduction
More informationWhat Do You Mean The Morphine Isn t Working? Objectives. Opioid Epidemic. Ellen Fulp, PharmD, BCGP Clinical Education Coordinator AvaCare, Inc.
What Do You Mean The Morphine Isn t Working? Ellen Fulp, PharmD, BCGP Clinical Education Coordinator AvaCare, Inc. 42 nd Annual Hospice & Palliative Care Conference September 2018 Charlotte, NC Objectives
More informationMeasure Summary: The opioid equivalency measure examines opioid administration for patients who undergo a surgical procedure.
Measure Abbreviation: Opioid Equivalency Data Collection Method: This informational measure (there is no threshold or target) is calculated based on data extracted from the electronic medical record combined
More informationPractical Pain Management Leah Centanni, MSN, FNP-C, Asst. Clinical Professor CANP Conference March 22, 2014
Practical Pain Management Leah Centanni, MSN, FNP-C, Asst. Clinical Professor CANP Conference March 22, 2014 Overview Types of Pain Physical Examination of Pain Pharmacologic Approach in Pain Management
More informationERAS: Enhanced Recovery After Surgery. Christopher L. Wu, M.D. Professor of Anesthesiology The Johns Hopkins University; Baltimore, Maryland
ERAS: Enhanced Recovery After Surgery Christopher L. Wu, M.D. Professor of Anesthesiology The Johns Hopkins University; Baltimore, Maryland Overview History and basic principles of ERAS Review published
More informationClinical Policy: Opioid Analgesics Reference Number: OH.PHAR.PPA.13 Effective Date: 10/2017 Last Review Date: 6/2018 Line of Business: Medicaid
Clinical Policy: Reference Number: OH.PHAR.PPA.13 Effective Date: 10/2017 Last Review Date: 6/2018 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important
More informationGoals for sedation during mechanical ventilation
New Uses of Old Medications Gina Riggi, PharmD, BCCCP, BCPS Clinical Pharmacist Trauma ICU Jackson Memorial Hospital Disclosure I do not have anything to disclose Objectives Describe the use of ketamine
More informationB. Long-acting/Extended-release Opioids
4 Opioid tolerance is assumed in patients already taking fentanyl 25 mcg/hr OR daily doses of the following oral agents for 1 week: 60 mg oral morphine, 30 mg oxycodone, 8 mg hydromorphone, 25 mg of oxymorphone
More informationOpioid reduction strategies in an academic tertiary medical center
Opioid reduction strategies in an academic tertiary medical center Terry Bosen, PharmD Medication Safety Program Director Vanderbilt University Medical Center Tennessee MME data per capita MME = Morphine
More informationJennifer Mando-Vandrick, PharmD, BCPS Clinical Pharmacist, Emergency Department Director, PGY2 Critical Care Pharmacy Residency Duke University
Jennifer Mando-Vandrick, PharmD, BCPS Clinical Pharmacist, Emergency Department Director, PGY2 Critical Care Pharmacy Residency Duke University Hospital Objectives Review pertinent pharmacotherapy common
More informationBree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT
Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup Opioid Prescribing Metrics - DRAFT Definitions: Days Supply: The total of all opioid prescriptions dispensed during the calendar quarter
More informationBJF Acute Pain Team Formulary Group
Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution
More informationPostoperative pain management: Analgesics, algorithms and patient activation
Postoperative pain management: Analgesics, algorithms and patient activation Alfred Deakin Prof. Mari Botti Deakin University/Epworth HealthCare Victorian Perioperative Nurses Group 60 th State Conference,
More informationAppendix A: Pharmacologic approaches to pain management during MVA
Pain medication Though the medications shown below are commonly used for pain management during uterine evacuation, many other options exist. This table does not cover general anesthetic agents. Both anxiolytics
More informationPharmacologic Considerations for Managing Sickle Cell Pain Claire Saadeh, PharmD, BCOP May 5, 2015
Pharmacologic Considerations for Managing Sickle Cell Pain Claire Saadeh, PharmD, BCOP May 5, 2015 Table 1: Physiologic changes that occur during sickle cell pain crisis 1-3 Phase Description / Complications
More information3/28/18. Navigating the Bumps and Dips: The Ins and Outs of Pectus Excavatum and Pectus Carinatum. Disclosure Information.
Navigating the Bumps and Dips: The Ins and Outs of Pectus Excavatum and Pectus Carinatum Beth Orrick, MSN, APRN, FNP-BC Amy Pierce, MSN, APRN, PPCNP-BC Children s Mercy Hospital Kansas City, MO Disclosure
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationLegacy Pain Management Center New Patient Questionnaire
Legacy Pain Management Center New Patient Questionnaire Please complete this form prior to your visit to allow us to make the best use of our time together. Primary Care Provider: Referring Physician:
More information